Treatment With α-1-Antitrypsin for Steroid-Refractory Acute Intestinal Graft-Versus- Host Disease: A Report of 2 Cases

被引:1
作者
Gerner, Romana Raphaela [1 ]
Feistritzer, Clemens [2 ]
Moschen, Alexander Rupert [1 ]
Kircher, Brigitte [2 ]
Moser, Patrizia [3 ]
Tilg, Herbert [1 ]
Nachbaur, David [2 ]
机构
[1] Med Univ Innsbruck, Univ Hosp Internal Med 1, Gastroenterol Endocrinol & Metab, Innsbruck, Austria
[2] Med Univ Innsbruck, Univ Hosp Internal Med 5, Hematol & Oncol, Innsbruck, Austria
[3] Med Univ Innsbruck, Dept Pathol, Innsbruck, Austria
关键词
MARROW-TRANSPLANTATION; FECAL CALPROTECTIN; GVHD;
D O I
10.1097/TP.0000000000001470
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:E158 / E159
页数:2
相关论文
共 50 条
  • [1] Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsin
    Gergoudis, Stephanie C.
    DeFilipp, Zachariah
    Ozbek, Umut
    Sandhu, Karamjeet S.
    Etra, Aaron M.
    Choe, Hannah K.
    Kitko, Carrie L.
    Ayuk, Francis
    Aziz, Mina
    Baez, Janna
    Ben-David, Kaitlyn
    Bunworasate, Udomsak
    Gandhi, Isha
    Hexner, Elizabeth O.
    Hogan, William J.
    Holler, Ernst
    Kasikis, Stelios
    Kowalyk, Steven M.
    Lin, Jung-Yi
    Merli, Pietro
    Morales, George
    Nakamura, Ryotaro
    Reshef, Ran
    Roesler, Wolf
    Srinagesh, Hrishikesh
    Young, Rachel
    Chen, Yi-Bin
    Ferrara, James L. M.
    Levine, John E.
    BLOOD ADVANCES, 2020, 4 (24) : 6098 - 6105
  • [2] Alpha-1-antitrypsin for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease
    Jerkins, James H.
    Hamadani, Mehdi
    Zook, Felicia
    Epperla, Narendranath
    Shaw, Bronwen E.
    Saber, Wael
    Rizzo, J. Douglas
    Pasquini, Marcelo
    Chhabra, Saurabh
    Drobyski, William R.
    Hari, Parameswaran N.
    Shah, Nirav N.
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (10) : E610 - E611
  • [3] A phase 2a randomized clinical trial of intravenous vedolizumab for the treatment of steroid-refractory intestinal acute graft-versus-host disease
    Floisand, Yngvar
    Schroeder, Mark A.
    Chevallier, Patrice
    Selleslag, Dominik
    Devine, Steven
    Renteria, Anne S.
    Mohty, Mohamad
    Yakoub-Agha, Ibrahim
    Chen, Chunlin
    Parfionovas, Andrejus
    Quadri, Syed
    Jansson, Johan
    Akbari, Mona
    Chen, Yi-Bin
    BONE MARROW TRANSPLANTATION, 2021, 56 (10) : 2477 - 2488
  • [4] Alemtuzumab for Severe Steroid-Refractory Gastrointestinal Acute Graft-versus-Host Disease
    Meunier, Mathieu
    Bulabois, Claude Eric
    Thiebaut-Bertrand, Anne
    Itzykson, Raphael
    Carre, Martin
    Carras, Sylvain
    Garban, Frederic
    Cahn, Jean Yves
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (09) : 1451 - 1454
  • [5] Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease
    Floisand, Yngvar
    Lundin, Knut E. A.
    Lazarevic, Vladimir
    Kristiansen, Jorn Dehli
    Osnes, Liv T. N.
    Tjonnfjord, Geir E.
    Reims, Henrik Mikael
    Gedde-Dahl, Tobias
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (01) : 172 - 175
  • [6] The successful use of alemtuzumab for treatment of steroid-refractory acute graft-versus-host disease in pediatric patients
    Khandelwal, Pooja
    Lawrence, Julia
    Filipovich, Alexandra H.
    Davies, Stella M.
    Bleesing, Jacob J.
    Jordan, Michael B.
    Mehta, Parinda
    Jodele, Sonata
    Grimley, Michael S.
    Kumar, Ashish
    Myers, Kasiani
    Marsh, Rebecca A.
    PEDIATRIC TRANSPLANTATION, 2014, 18 (01) : 94 - 102
  • [7] Effectiveness of intra-arterial steroid administration for the treatment of steroid-refractory acute gastrointestinal graft-versus-host disease
    Berczi, V
    Toth, A.
    Tatai, G.
    Fabian, J.
    Remenyi, P.
    Masszi, T.
    CLINICAL RADIOLOGY, 2019, 74 (04) : 301 - 305
  • [8] Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience
    De Jong, Cornelis N.
    Saes, Lotte
    Klerk, Clara P. W.
    Van der Klift, Marjolein
    Cornelissen, Jan J.
    Broers, Annoek E. C.
    PLOS ONE, 2017, 12 (10):
  • [9] Vedolizumab therapy for pediatric steroid-refractory gastrointestinal acute graft-versus-host disease
    Kyohei Isshiki
    Takahiro Kamiya
    Akifumi Endo
    Kentaro Okamoto
    Tomoo Osumi
    Toshinao Kawai
    Katsuhiro Arai
    Daisuke Tomizawa
    Kazuo Ohtsuka
    Masakazu Nagahori
    Kohsuke Imai
    Motohiro Kato
    Hirokazu Kanegane
    International Journal of Hematology, 2022, 115 : 590 - 594
  • [10] Vedolizumab therapy for pediatric steroid-refractory gastrointestinal acute graft-versus-host disease
    Isshiki, Kyohei
    Kamiya, Takahiro
    Endo, Akifumi
    Okamoto, Kentaro
    Osumi, Tomoo
    Kawai, Toshinao
    Arai, Katsuhiro
    Tomizawa, Daisuke
    Ohtsuka, Kazuo
    Nagahori, Masakazu
    Imai, Kohsuke
    Kato, Motohiro
    Kanegane, Hirokazu
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (04) : 590 - 594